NCT06903650

Brief Summary

This study aimed to evaluate the effect of salpingectomy operation on ovarian reserve. Ovarian reserve was evaluated by measuring anti-mullerian hormone levels from serum samples taken from the patients before the operation and 6 weeks after the operation. Ovarian doppler flow were evaluated by measuring the ovarian artery pulsatility index with transvaginal ultrasonography preoperatively, postoperative days 2 and postoperative weeks 6 . In our study, it was determined that ovarian functions may be negatively affected in the acute period after salpingectomy operation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 27, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2021

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 31, 2025

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

March 21, 2025

Last Update Submit

March 31, 2025

Conditions

Keywords

SalpingectomyOvarian ReserveAnti-Mullerian HormoneDoppler Ultrasonography

Outcome Measures

Primary Outcomes (3)

  • right ovarian arter pı

    rate of 0,87/ 0,84/ 0,76

    perioperative, postoperative days 2 , postoperative weeks 6

  • left ovarian arter pı

    rate of 0,89/ 0,79/ 0.80

    perioperative, postoperative days 2, postoperative weeks 6

  • AMH levels

    Concentration of 1 ng/mL / 0,79 ng/mL

    perioperative-postoperative weeks 6

Study Arms (3)

perioperative ovarian arter pulsatility index(PI)(right and left), perioperative AMH levels

Procedure: bilateral salpingectomy, ovarian arter doppler ultrasonography

postoperative days 2 ovarian arter pulsatility index (PI) (right and left)

Procedure: bilateral salpingectomy, ovarian arter doppler ultrasonography

postop. weeks 6 ovarian arter pulsatility index(PI)(right and left), postop. weeks 6 AMH levels

Procedure: bilateral salpingectomy, ovarian arter doppler ultrasonography

Interventions

The effect of salpingectomy operation on ovarian reserve

perioperative ovarian arter pulsatility index(PI)(right and left), perioperative AMH levelspostop. weeks 6 ovarian arter pulsatility index(PI)(right and left), postop. weeks 6 AMH levelspostoperative days 2 ovarian arter pulsatility index (PI) (right and left)

Eligibility Criteria

Age37 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Serum samples will be separated from routine blood samples taken from patients who apply to the outpatient clinic and will undergo salpingectomy within the indication, during perioperative preparation and at the 6th week postoperatively, after patient consent is obtained. This serum sample will be taken into an Eppendorf tube and kept at -40˚C for later AMH levels to be studied. Ovarian artery pulsatility index values measured during the patient's perioperative and postoperative routine ultrasonographic examination and weeks 6 postoperative control will be recorded.

You may qualify if:

  • Women between the ages of 37-45 with continuing menstrual cycles (37 and 45 included)
  • Patients who will undergo uterine surgery for benign reasons or who will undergo salpingectomy only due to hydrosalpinx, ectopic pregnancy, tubo-ovarian abscess
  • Patients who have not had ovarian surgery before
  • Those without menopause and premature ovarian failure
  • Patients who accept the study

You may not qualify if:

  • Age younger than 37 or older than 45
  • Those who want to withdraw from the study
  • Those who do not come for follow-up examination
  • Use of drugs that affect ovarian reserve
  • Any surgical procedure performed on the ovaries during the operation
  • No menstrual bleeding in the last year
  • Patients who received radiotherapy and hormonal therapy within 3 months before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylul University School of Medicine

Izmir, 35000, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 31, 2025

Study Start

October 27, 2020

Primary Completion

March 3, 2021

Study Completion

June 5, 2021

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations